Sort
15,842 grants matching “pancreatic cancer”
Tumor Suppression by Telomere Dysfunction Induced Senescence
$310,426Utz Herbig · Rbhs-New Jersey Medical School · R01 · FY2014 · CA
MicroRNA-1291 in Regulation of Xenobiotic Disposition and Cell Differentiation
$310,326Aiming Yu · University Of California At Davis · U01 · FY2017 · CA
TGF-beta Signaling in Pancreatic Cancer Progression
$310,286Christine A Iacobuzio-Donahue · Johns Hopkins University · R01 · FY2013 · CA
Dual Targeting of MEK and EGFR Signaling Pathways in Advanced Pancreatic Cancer
$310,267Andrew H Ko · University Of California, San Francisco · R21 · FY2011 · CA
Pancreatic Cancer Management by Novel Gene Therapy & Dietary Agents
$310,213Paul B Fisher · Virginia Commonwealth University · R01 · FY2010 · CA
Smo regulation by Ptch1 and Ptch2
$310,187Henk Roelink · University Of California Berkeley · R01 · FY2016 · GM
Interplay of Tumor Microenvironment and MUC4 in Pancreatic Cancer
$310,162Surinder Kumar Batra · University Of Nebraska Medical Center · U54 · FY2013 · CA
Pancreatic Cancer Management by Novel Gene Therapy & Dietary Agents
$310,126Paul B Fisher · Virginia Commonwealth University · R01 · FY2009 · CA
Matricellular proteins as regulators of tumor progression
$310,125Rolf A Brekken · Ut Southwestern Medical Center · R01 · FY2007 · CA
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors
$310,115Michael Bouvet · University Of California, San Diego · R01 · FY2012 · CA
Project 2: Biological Effects of Patient-derived Mutations in MUC16 on PC Metastasis
$310,110Michael A Hollingsworth · University Of Nebraska Medical Center · P01 · FY2022 · CA
Project 3: MUC16-Mediated Metabolic Reprograming Induces PC Metastasis
$310,109Pankaj Kumar Singh · University Of Nebraska Medical Center · P01 · FY2022 · CA
Project 3: Combination inhibition of ERK for pancreatic cancer treatment
$310,080Andrea Wang-Gillam · Washington University · P50 · FY2016 · CA
Eosinophil Recruitment and Activation in Solid Tumors
$310,075Mayo Clinic Arizona · R01 · FY2005 · CA
HRD-IA signatures in pancreatic ductal adenocarcinoma
$310,005Michael T Barrett · Mayo Clinic Arizona · UH3 · FY2022 · CA
THE REPLICATION STRESS RESPONSE IN PANCREATIC CANCER
$310,000Emory University · · FY2012 · Department of the Army
EAGER: Complete 3D imaging of needle biopsy to diagnose pancreatic cancer
$309,999Eric J Seibel · University Of Washington · · FY2012 · ENG
Chemoprevention by a Targeted Thioredoxin Inhibitor.
$309,964Garth Powis · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
The 26S Proteasome in Cancer Stem Cells
$309,964Frank Pajonk · University Of California Los Angeles · R01 · FY2012 · CA
Cyclooxygenase-2 Induced Pancreatic Cancer
$309,964Susan M Fischer · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Therapeutic targeting of stratifin structure and function
$309,964Jian-Ting Zhang · Indiana University Indianapolis · R01 · FY2012 · CA
The 26S Proteasome in Cancer Stem Cells
$309,964Frank Pajonk · University Of California Los Angeles · R01 · FY2011 · CA
Cyclooxygenase-2 Induced Pancreatic Cancer
$309,964Susan M Fischer · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Therapeutic targeting of stratifin structure and function
$309,964Jian-Ting Zhang · Indiana University Indianapolis · R01 · FY2011 · CA
Enhancing immune therapy in pancreatic cancer by targeting IL-6
$309,956Gregory B. Lesinski · Emory University · R01 · FY2019 · CA